🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, single-arm, multi-center clinical trial to evaluate ...
Status
Recruiting
Location
Changzhou Municipal No.1 People's Hospital
Start Date
2023-02-20
Trial ID
NCT05736965
Treatments Being Tested
Allogeneic hematopoietic stem cell transplantation is an important treatmen...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-30
Trial ID
NCT07276698
Treatments Being Tested
This study aims to evaluate the efficacy and safety of selinexor-based chem...
Status
Completed
Location
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Start Date
2025-01-01
Trial ID
NCT07236931
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of selinex...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2023-05-01
Trial ID
NCT05805072
This is a phase I/II study evaluate the safety and efficacy targeted agents...
Status
Not Yet Recruiting
Location
Ruijin Hospital
Start Date
2026-07
Trial ID
NCT07706959
This study includes Phase I and Phase II stages. Phase I is an open-label t...
Status
Recruiting
Location
Ruijin hospital
Start Date
2023-02-13
Trial ID
NCT05675813
The purpose of this study is to see if selinexor will improve the blood cou...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2014-08-27
Trial ID
NCT02228525
Treatments Being Tested
This study is a single arm open exploratory clinical trial to evaluate the ...
Status
Terminated
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2023-05-05
Trial ID
NCT06449482
Treatments Being Tested
To explore the safety and efficacy of selinexor combined with azacitidine a...
Status
Active Not Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-05-01
Trial ID
NCT07779031
Treatments Being Tested
This phase I trial studies the side effects and best dose of Selinexor when...
Status
Completed
Location
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Start Date
2014-03
Trial ID
NCT02093403
Treatments Being Tested